Connect with us

Uncategorized

Forensic technologies market 2023-2027: Growth opportunities led by AB SCIEX LLC and Agilent Technologies Inc. – Technavio

Forensic technologies market 2023-2027: Growth opportunities led by AB SCIEX LLC and Agilent Technologies Inc. – Technavio
PR Newswire
NEW YORK, Feb. 7, 2023

NEW YORK, Feb. 7, 2023 /PRNewswire/ — The forensic technologies market size is estimated …

Published

on

Forensic technologies market 2023-2027: Growth opportunities led by AB SCIEX LLC and Agilent Technologies Inc. - Technavio

PR Newswire

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The forensic technologies market size is estimated to increase by USD 6,583.87 million from 2022 to 2027, with a CAGR of 11.89%, according to a recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region. Discover some insights on market size before buying the full report - Request a sample report

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. the bargaining power of buyers & suppliers and the threat of new entrants, rivalry, and substitutes have also been analyzed and rated between LOW-HIGH to provide a holistic view of market favorability.

To procure the data - Buy report!

Find Technavio's exclusive analysis of price sensitivity, adoption lifecycle, customer purchase basket, adoption rates, and purchase criteria

  • One of the core components of the customer landscape is price sensitivity, an analysis of which will help companies refine marketing strategies to gain a competitive advantage
  • Another key aspect is price sensitivity drivers (purchases are undifferentiated, the purchase is a key cost to buyers, and quality is not important), which range between LOW and NEUTRAL.
  • Furthermore, market adoption rates for all regions have been covered.

The addictions therapeutics market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed below -

  • AB SCIEX LLC
  • Agilent Technologies Inc.
  • BDO International Ltd.
  • Belkasoft
  • Danaher Corp.
  • Eurofins Scientific SE
  • Exterro Inc.
  • HORIBA Ltd.
  • Illumina Inc.
  • LGC Ltd.
  • LIFARS LLC
  • Neogen Corp.
  • NMS Labs
  • Perkin Elmer Inc
  • Promega Corp.
  • QIAGEN NV
  • Shimadzu Corp.
  • StoneTurn Group LLP
  • Thermo Fisher Scientific Inc.
  • Ultra Electronics Holdings Plc
  • Zentek Digital Investigations Ltd.

Download a sample

Chart & data table on 5-year historic (2017-2021) market size, comparative analysis of segments, and y-o-y growth of forensic technologies market

  • The market is segmented by application (law enforcement agencies, healthcare, and others) and technique (PCR, capillary electrophoresis, and others).
  • Based on technique, the PCR segment will account for a significant share of the market's growth during the forecast period.
  • PCR is a forensic technique used in DNA fingerprinting for human identification. Forensic analyses utilize short tandem repeats (STRs) to differentiate between different individuals.
  • It facilitates the analysis of DNA from old or degraded samples and amplifies the DNA fragments into several billion copies.
  • Moreover, the method ensures accurate measurement of DNA for STR analysis using a small sample, which increases efficiency and reduces the cost of reamplification.
  • Such factors are expected to drive the growth of the PCR segment in the market during the forecast period.

Need for better investigation methods due to the increasing crime rate is driving the forensic technologies market growth

Crime rates have increased worldwide, which require advanced technologies and intelligence. Forensic technologies are crucial in criminal investigations. A rise in the number of criminal cases has increased the backlog of pending cases. This led to an increase in the number of laboratories globally. Moreover, heavily financed research has created a demand for high-quality forensic products and services. Such factors will fuel the market growth during the forecast period.

Chart & data table on historical market size (2017-2021), historic industry size, and analysis of vendors and countries
The market is segmented by region (North America, Europe, Asia, and Rest of World (ROW)). An analysis of key leading countries has been included.

  • North America is estimated to account for 33% of the growth of the global market during the forecast period. High funding by governments to forensic labs and the presence of major vendors are driving the market growth in this region. The US, Canada, and Mexico are the key contributors to the market growth. The growing crime rates and government initiatives to combat such issues are increasing the demand for forensic technologies in the region.
  • The outbreak of COVID-19 led to the closure of forensic labs, which negatively impacted the market in the region. However, the rise in adoption of genome sequencing technology has boosted the demand for various forensic technologies. Moreover, forensic labs reopened in 2021 with routine activities resuming in the region. The rise healthcare expenditure in the region is expected to boost the growth of the market in North America during the forecast period.

For insights on the market dynamics and segmentations, view PDF sample!

Related Reports:

Transfection Technologies Market Research Report, Size , Growth, Trends, Opportunity Analysis, Industry Forecast - 2022-2026 - size is projected to grow by USD 526.14 million with a CAGR of 9.05%, during the forecast period 2021 to 2026, according to the recent market study by Technavio. Furthermore, this report extensively covers transfection technologies market segmentation by end-user (pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes) and geography (North America, Asia, Europe, and the Rest of the World (ROW)). To get more exclusive research insights: view summary of the report.

Cell Culture Consumables Market by Application, and Geography - Forecast and Analysis 2023-2027 – size is forecasted to increase by USD 23,729.7 million. The market is estimated to grow at a CAGR of 22.3% between 2022 and 2027. This report extensively covers market segmentation by application (biopharmaceutical production, cancer research, and others) and geography (North America, Europe, Asia, and Rest of World). To get more exclusive research insights: view summary of the report

Register for a free trial today and gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

What are the key data covered in this forensic technologies market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the forensic technologies market between 2023 and 2027
  • Precise estimation of the size of the forensic technologies market and its contribution to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the forensic technologies market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of Forensic Technologies Market vendors

Forensic Technologies Market Scope

Report Coverage

Details

Page number

165

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.89%

Market growth 2023-2027

USD 6,583.87 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

9.95

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key countries

US, UK, Germany, China, and Japan

Competitive landscape

Leading vendors, market positioning of vendors, competitive strategies, and industry risks

Key companies profiled

AB SCIEX LLC, Agilent Technologies Inc., BDO International Ltd., Belkasoft, Danaher Corp., Eurofins Scientific SE, Exterro Inc., HORIBA Ltd., Illumina Inc., LGC Ltd., LIFARS LLC, Neogen Corp., NMS Labs, Perkin Elmer Inc, Promega Corp., QIAGEN NV, Shimadzu Corp., StoneTurn Group LLP, Thermo Fisher Scientific Inc., Ultra Electronics Holdings Plc, and Zentek Digital Investigations Ltd.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio's health care market reports

Table of contents

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technique
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global forensic technologies market 2017 - 2021
    • Exhibit 18: Historic Market Size – Data Table on Global forensic technologies market 2017 - 2021 ($ million)
  • 4.2 Technique Segment Analysis 2017 - 2021 
    • Exhibit 19: Historic Market Size – Technique Segment 2017 - 2021 ($ million)
  • 4.3 Application Segment Analysis 2017 - 2021
    • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technique

  • 6.1 Market segments 
    • Exhibit 30: Chart on Technique - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Technique - Market share 2022-2027 (%)
  • 6.2 Comparison by Technique 
    • Exhibit 32: Chart on Comparison by Technique
    • Exhibit 33: Data Table on Comparison by Technique
  • 6.3 PCR - Market size and forecast 2022-2027
    • Exhibit 34: Chart on PCR - Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on PCR - Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on PCR - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on PCR - Year-over-year growth 2022-2027 (%)
  • 6.4 Capillary electrophoresis - Market size and forecast 2022-2027 
    • Exhibit 38: Chart on Capillary electrophoresis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Capillary electrophoresis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Capillary electrophoresis - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Capillary electrophoresis - Year-over-year growth 2022-2027 (%)
  • 6.5 Others - Market size and forecast 2022-2027
    • Exhibit 42: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.6 Market opportunity by Technique 
    • Exhibit 46: Market opportunity by Technique ($ million)

7 Market Segmentation by Application

  • 7.1 Market segments 
    • Exhibit 47: Chart on Application - Market share 2022-2027 (%)
    • Exhibit 48: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application 
    • Exhibit 49: Chart on Comparison by Application
    • Exhibit 50: Data Table on Comparison by Application
  • 7.3 Law enforcement agencies - Market size and forecast 2022-2027 
    • Exhibit 51: Chart on Law enforcement agencies - Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Data Table on Law enforcement agencies - Market size and forecast 2022-2027 ($ million)
    • Exhibit 53: Chart on Law enforcement agencies - Year-over-year growth 2022-2027 (%)
    • Exhibit 54: Data Table on Law enforcement agencies - Year-over-year growth 2022-2027 (%)
  • 7.4 Healthcare - Market size and forecast 2022-2027
    • Exhibit 55: Chart on Healthcare - Market size and forecast 2022-2027 ($ million)
    • Exhibit 56: Data Table on Healthcare - Market size and forecast 2022-2027 ($ million)
    • Exhibit 57: Chart on Healthcare - Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on Healthcare - Year-over-year growth 2022-2027 (%)
  • 7.5 Others - Market size and forecast 2022-2027
    • Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Application 
    • Exhibit 63: Market opportunity by Application ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 65: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 67: Chart on Geographic comparison
    • Exhibit 68: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
    • Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
    • Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
    • Exhibit 77: Chart on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 78: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 79: Chart on Asia - Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
    • Exhibit 81: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
    • Exhibit 85: Chart on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
    • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 UK - Market size and forecast 2022-2027
    • Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
  • 9.10 Germany - Market size and forecast 2022-2027
    • Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
    • Exhibit 101: Chart on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 108: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 109: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 110: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 111: Matrix on vendor position and classification
  • 12.3 AB SCIEX LLC 
    • Exhibit 112: AB SCIEX LLC - Overview
    • Exhibit 113: AB SCIEX LLC - Product / Service
    • Exhibit 114: AB SCIEX LLC - Key offerings
  • 12.4 Agilent Technologies Inc. 
    • Exhibit 115: Agilent Technologies Inc. - Overview
    • Exhibit 116: Agilent Technologies Inc. - Business segments
    • Exhibit 117: Agilent Technologies Inc. - Key news
    • Exhibit 118: Agilent Technologies Inc. - Key offerings
    • Exhibit 119: Agilent Technologies Inc. - Segment focus
  • 12.5 BDO International Ltd. 
    • Exhibit 120: BDO International Ltd. - Overview
    • Exhibit 121: BDO International Ltd. - Business segments
    • Exhibit 122: BDO International Ltd. - Key offerings
    • Exhibit 123: BDO International Ltd. - Segment focus
  • 12.6 Danaher Corp. 
    • Exhibit 124: Danaher Corp. - Overview
    • Exhibit 125: Danaher Corp. - Business segments
    • Exhibit 126: Danaher Corp. - Key news
    • Exhibit 127: Danaher Corp. - Key offerings
    • Exhibit 128: Danaher Corp. - Segment focus
  • 12.7 Exterro Inc. 
    • Exhibit 129: Exterro Inc. - Overview
    • Exhibit 130: Exterro Inc. - Product / Service
    • Exhibit 131: Exterro Inc. - Key offerings
  • 12.8 HORIBA Ltd. 
    • Exhibit 132: HORIBA Ltd. - Overview
    • Exhibit 133: HORIBA Ltd. - Business segments
    • Exhibit 134: HORIBA Ltd. - Key news
    • Exhibit 135: HORIBA Ltd. - Key offerings
    • Exhibit 136: HORIBA Ltd. - Segment focus
  • 12.9 Illumina Inc. 
    • Exhibit 137: Illumina Inc. - Overview
    • Exhibit 138: Illumina Inc. - Business segments
    • Exhibit 139: Illumina Inc. - Key news
    • Exhibit 140: Illumina Inc. - Key offerings
    • Exhibit 141: Illumina Inc. - Segment focus
  • 12.10 LGC Ltd. 
    • Exhibit 142: LGC Ltd. - Overview
    • Exhibit 143: LGC Ltd. - Product / Service
    • Exhibit 144: LGC Ltd. - Key offerings
  • 12.11 Neogen Corp. 
    • Exhibit 145: Neogen Corp. - Overview
    • Exhibit 146: Neogen Corp. - Business segments
    • Exhibit 147: Neogen Corp. - Key news
    • Exhibit 148: Neogen Corp. - Key offerings
    • Exhibit 149: Neogen Corp. - Segment focus
  • 12.12 NMS Labs 
    • Exhibit 150: NMS Labs - Overview
    • Exhibit 151: NMS Labs - Product / Service
    • Exhibit 152: NMS Labs - Key offerings
  • 12.13 Promega Corp. 
    • Exhibit 153: Promega Corp. - Overview
    • Exhibit 154: Promega Corp. - Product / Service
    • Exhibit 155: Promega Corp. - Key offerings
  • 12.14 QIAGEN NV 
    • Exhibit 156: QIAGEN NV - Overview
    • Exhibit 157: QIAGEN NV - Product / Service
    • Exhibit 158: QIAGEN NV - Key news
    • Exhibit 159: QIAGEN NV - Key offerings
  • 12.15 Shimadzu Corp. 
    • Exhibit 160: Shimadzu Corp. - Overview
    • Exhibit 161: Shimadzu Corp. - Business segments
    • Exhibit 162: Shimadzu Corp. - Key news
    • Exhibit 163: Shimadzu Corp. - Key offerings
    • Exhibit 164: Shimadzu Corp. - Segment focus
  • 12.16 Thermo Fisher Scientific Inc. 
    • Exhibit 165: Thermo Fisher Scientific Inc. - Overview
    • Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
    • Exhibit 167: Thermo Fisher Scientific Inc. - Key news
    • Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
    • Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus
  • 12.17 Ultra Electronics Holdings Plc 
    • Exhibit 170: Ultra Electronics Holdings Plc - Overview
    • Exhibit 171: Ultra Electronics Holdings Plc - Business segments
    • Exhibit 172: Ultra Electronics Holdings Plc - Key offerings
    • Exhibit 173: Ultra Electronics Holdings Plc - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 174: Inclusions checklist
    • Exhibit 175: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 176: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 177: Research methodology
    • Exhibit 178: Validation techniques employed for market sizing
    • Exhibit 179: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 180: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/forensic-technologies-market-2023-2027-growth-opportunities-led-by-ab-sciex-llc-and-agilent-technologies-inc---technavio-301739216.html

SOURCE Technavio

Read More

Continue Reading

Uncategorized

Digital Currency And Gold As Speculative Warnings

Over the last few years, digital currencies and gold have become decent barometers of speculative investor appetite. Such isn’t surprising given the evolution…

Published

on

Over the last few years, digital currencies and gold have become decent barometers of speculative investor appetite. Such isn’t surprising given the evolution of the market into a “casino” following the pandemic, where retail traders have increased their speculative appetites.

“Such is unsurprising, given that retail investors often fall victim to the psychological behavior of the “fear of missing out.” The chart below shows the “dumb money index” versus the S&P 500. Once again, retail investors are very long equities relative to the institutional players ascribed to being the “smart money.””

“The difference between “smart” and “dumb money” investors shows that, more often than not, the “dumb money” invests near market tops and sells near market bottoms.”

Net Smart Dumb Money vs Market

That enthusiasm has increased sharply since last November as stocks surged in hopes that the Federal Reserve would cut interest rates. As noted by Sentiment Trader:

“Over the past 18 weeks, the straight-up rally has moved us to an interesting juncture in the Sentiment Cycle. For the past few weeks, the S&P 500 has demonstrated a high positive correlation to the ‘Enthusiasm’ part of the cycle and a highly negative correlation to the ‘Panic’ phase.”

Investor Enthusiasm

That frenzy to chase the markets, driven by the psychological bias of the “fear of missing out,” has permeated the entirety of the market. As noted in This Is Nuts:”

“Since then, the entire market has surged higher following last week’s earnings report from Nvidia (NVDA). The reason I say “this is nuts” is the assumption that all companies were going to grow earnings and revenue at Nvidia’s rate. There is little doubt about Nvidia’s earnings and revenue growth rates. However, to maintain that growth pace indefinitely, particularly at 32x price-to-sales, means others like AMD and Intel must lose market share.”

Nvidia Price To Sales

Of course, it is not just a speculative frenzy in the markets for stocks, specifically anything related to “artificial intelligence,” but that exuberance has spilled over into gold and cryptocurrencies.

Birds Of A Feather

There are a couple of ways to measure exuberance in the assets. While sentiment measures examine the broad market, technical indicators can reflect exuberance on individual asset levels. However, before we get to our charts, we need a brief explanation of statistics, specifically, standard deviation.

As I discussed in “Revisiting Bob Farrell’s 10 Investing Rules”:

“Like a rubber band that has been stretched too far – it must be relaxed in order to be stretched again. This is exactly the same for stock prices that are anchored to their moving averages. Trends that get overextended in one direction, or another, always return to their long-term average. Even during a strong uptrend or strong downtrend, prices often move back (revert) to a long-term moving average.”

The idea of “stretching the rubber band” can be measured in several ways, but I will limit our discussion this week to Standard Deviation and measuring deviation with “Bollinger Bands.”

“Standard Deviation” is defined as:

“A measure of the dispersion of a set of data from its mean. The more spread apart the data, the higher the deviation. Standard deviation is calculated as the square root of the variance.”

In plain English, this means that the further away from the average that an event occurs, the more unlikely it becomes. As shown below, out of 1000 occurrences, only three will fall outside the area of 3 standard deviations. 95.4% of the time, events will occur within two standard deviations.

Standard Deviation Chart

A second measure of “exuberance” is “relative strength.”

“In technical analysis, the relative strength index (RSI) is a momentum indicator that measures the magnitude of recent price changes to evaluate overbought or oversold conditions in the price of a stock or other asset. The RSI is displayed as an oscillator (a line graph that moves between two extremes) and can read from 0 to 100.

Traditional interpretation and usage of the RSI are that values of 70 or above indicate that a security is becoming overbought or overvalued and may be primed for a trend reversal or corrective pullback in price. An RSI reading of 30 or below indicates an oversold or undervalued condition.” – Investopedia

With those two measures, let’s look at Nvidia (NVDA), the poster child of speculative momentum trading in the markets. Nvidia trades more than 3 standard deviations above its moving average, and its RSI is 81. The last time this occurred was in July of 2023 when Nvidia consolidated and corrected prices through November.

NVDA chart vs Bollinger Bands

Interestingly, gold also trades well into 3 standard deviation territory with an RSI reading of 75. Given that gold is supposed to be a “safe haven” or “risk off” asset, it is instead getting swept up in the current market exuberance.

Gold vs Bollinger Bands

The same is seen with digital currencies. Given the recent approval of spot, Bitcoin exchange-traded funds (ETFs), the panic bid to buy Bitcoin has pushed the price well into 3 standard deviation territory with an RSI of 73.

Bitcoin vs Bollinger Bands

In other words, the stock market frenzy to “buy anything that is going up” has spread from just a handful of stocks related to artificial intelligence to gold and digital currencies.

It’s All Relative

We can see the correlation between stock market exuberance and gold and digital currency, which has risen since 2015 but accelerated following the post-pandemic, stimulus-fueled market frenzy. Since the market, gold and cryptocurrencies, or Bitcoin for our purposes, have disparate prices, we have rebased the performance to 100 in 2015.

Gold was supposed to be an inflation hedge. Yet, in 2022, gold prices fell as the market declined and inflation surged to 9%. However, as inflation has fallen and the stock market surged, so has gold. Notably, since 2015, gold and the market have moved in a more correlated pattern, which has reduced the hedging effect of gold in portfolios. In other words, during the subsequent market decline, gold will likely track stocks lower, failing to provide its “wealth preservation” status for investors.

SP500 vs Gold

The same goes for cryptocurrencies. Bitcoin is substantially more volatile than gold and tends to ebb and flow with the overall market. As sentiment surges in the S&P 500, Bitcoin and other cryptocurrencies follow suit as speculative appetites increase. Unfortunately, for individuals once again piling into Bitcoin to chase rising prices, if, or when, the market corrects, the decline in cryptocurrencies will likely substantially outpace the decline in market-based equities. This is particularly the case as Wall Street can now short the spot-Bitcoin ETFs, creating additional selling pressure on Bitcoin.

SP500 vs Bitcoin

Just for added measure, here is Bitcoin versus gold.

Gold vs Bitcoin

Not A Recommendation

There are many narratives surrounding the markets, digital currency, and gold. However, in today’s market, more than in previous years, all assets are getting swept up into the investor-feeding frenzy.

Sure, this time could be different. I am only making an observation and not an investment recommendation.

However, from a portfolio management perspective, it will likely pay to remain attentive to the correlated risk between asset classes. If some event causes a reversal in bullish exuberance, cash and bonds may be the only place to hide.

The post Digital Currency And Gold As Speculative Warnings appeared first on RIA.

Read More

Continue Reading

Uncategorized

Aging at AACR Annual Meeting 2024

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging…

Published

on

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Credit: Impact Journals

BUFFALO, NY- March 11, 2024 – Impact Journals publishes scholarly journals in the biomedical sciences with a focus on all areas of cancer and aging research. Aging is one of the most prominent journals published by Impact Journals

Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) Annual Meeting 2024 from April 5-10 at the San Diego Convention Center in San Diego, California. This year, the AACR meeting theme is “Inspiring Science • Fueling Progress • Revolutionizing Care.”

Visit booth #4159 at the AACR Annual Meeting 2024 to connect with members of the Aging team.

About Aging-US:

Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan. The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

Aging is indexed and archived by PubMed/Medline (abbreviated as “Aging (Albany NY)”), PubMed CentralWeb of Science: Science Citation Index Expanded (abbreviated as “Aging‐US” and listed in the Cell Biology and Geriatrics & Gerontology categories), Scopus (abbreviated as “Aging” and listed in the Cell Biology and Aging categories), Biological Abstracts, BIOSIS Previews, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

Please visit our website at www.Aging-US.com​​ and connect with us:

  • Aging X
  • Aging Facebook
  • Aging Instagram
  • Aging YouTube
  • Aging LinkedIn
  • Aging SoundCloud
  • Aging Pinterest
  • Aging Reddit

Click here to subscribe to Aging publication updates.

For media inquiries, please contact media@impactjournals.com.


Read More

Continue Reading

Uncategorized

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked…

Published

on

NY Fed Finds Medium, Long-Term Inflation Expectations Jump Amid Surge In Stock Market Optimism

One month after the inflation outlook tracked by the NY Fed Consumer Survey extended their late 2023 slide, with 3Y inflation expectations in January sliding to a record low 2.4% (from 2.6% in December), even as 1 and 5Y inflation forecasts remained flat, moments ago the NY Fed reported that in February there was a sharp rebound in longer-term inflation expectations, rising to 2.7% from 2.4% at the three-year ahead horizon, and jumping to 2.9% from 2.5% at the five-year ahead horizon, while the 1Y inflation outlook was flat for the 3rd month in a row, stuck at 3.0%. 

The increases in both the three-year ahead and five-year ahead measures were most pronounced for respondents with at most high school degrees (in other words, the "really smart folks" are expecting deflation soon). The survey’s measure of disagreement across respondents (the difference between the 75th and 25th percentile of inflation expectations) decreased at all horizons, while the median inflation uncertainty—or the uncertainty expressed regarding future inflation outcomes—declined at the one- and three-year ahead horizons and remained unchanged at the five-year ahead horizon.

Going down the survey, we find that the median year-ahead expected price changes increased by 0.1 percentage point to 4.3% for gas; decreased by 1.8 percentage points to 6.8% for the cost of medical care (its lowest reading since September 2020); decreased by 0.1 percentage point to 5.8% for the cost of a college education; and surprisingly decreased by 0.3 percentage point for rent to 6.1% (its lowest reading since December 2020), and remained flat for food at 4.9%.

We find the rent expectations surprising because it is happening just asking rents are rising across the country.

At the same time as consumers erroneously saw sharply lower rents, median home price growth expectations remained unchanged for the fifth consecutive month at 3.0%.

Turning to the labor market, the survey found that the average perceived likelihood of voluntary and involuntary job separations increased, while the perceived likelihood of finding a job (in the event of a job loss) declined. "The mean probability of leaving one’s job voluntarily in the next 12 months also increased, by 1.8 percentage points to 19.5%."

Mean unemployment expectations - or the mean probability that the U.S. unemployment rate will be higher one year from now - decreased by 1.1 percentage points to 36.1%, the lowest reading since February 2022. Additionally, the median one-year-ahead expected earnings growth was unchanged at 2.8%, remaining slightly below its 12-month trailing average of 2.9%.

Turning to household finance, we find the following:

  • The median expected growth in household income remained unchanged at 3.1%. The series has been moving within a narrow range of 2.9% to 3.3% since January 2023, and remains above the February 2020 pre-pandemic level of 2.7%.
  • Median household spending growth expectations increased by 0.2 percentage point to 5.2%. The increase was driven by respondents with a high school degree or less.
  • Median year-ahead expected growth in government debt increased to 9.3% from 8.9%.
  • The mean perceived probability that the average interest rate on saving accounts will be higher in 12 months increased by 0.6 percentage point to 26.1%, remaining below its 12-month trailing average of 30%.
  • Perceptions about households’ current financial situations deteriorated somewhat with fewer respondents reporting being better off than a year ago. Year-ahead expectations also deteriorated marginally with a smaller share of respondents expecting to be better off and a slightly larger share of respondents expecting to be worse off a year from now.
  • The mean perceived probability that U.S. stock prices will be higher 12 months from now increased by 1.4 percentage point to 38.9%.
  • At the same time, perceptions and expectations about credit access turned less optimistic: "Perceptions of credit access compared to a year ago deteriorated with a larger share of respondents reporting tighter conditions and a smaller share reporting looser conditions compared to a year ago."

Also, a smaller percentage of consumers, 11.45% vs 12.14% in prior month, expect to not be able to make minimum debt payment over the next three months

Last, and perhaps most humorous, is the now traditional cognitive dissonance one observes with these polls, because at a time when long-term inflation expectations jumped, which clearly suggests that financial conditions will need to be tightened, the number of respondents expecting higher stock prices one year from today jumped to the highest since November 2021... which incidentally is just when the market topped out during the last cycle before suffering a painful bear market.

Tyler Durden Mon, 03/11/2024 - 12:40

Read More

Continue Reading

Trending